The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Nov. 24, 2015
Filed:
Sep. 26, 2013
Applicant:
Idenix Pharmaceuticals Llc, Cambridge, MA (US);
Inventors:
Benjamin Alexander Mayes, Boston, MA (US);
Adel M. Moussa, Burlington, MA (US);
Assignee:
IDENIX PHARMACEUTICALS LLC, Cambridge, MA (US);
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07H 19/10 (2006.01); C07H 19/20 (2006.01); A61K 31/7076 (2006.01); C07H 17/02 (2006.01); A61K 45/06 (2006.01); C07H 19/16 (2006.01); A61K 31/403 (2006.01); A61K 31/497 (2006.01); A61K 31/7056 (2006.01); A61K 31/708 (2006.01); A61K 38/21 (2006.01);
U.S. Cl.
CPC ...
A61K 31/7076 (2013.01); A61K 31/403 (2013.01); A61K 31/497 (2013.01); A61K 31/708 (2013.01); A61K 31/7056 (2013.01); A61K 38/212 (2013.01); A61K 45/06 (2013.01); C07H 17/02 (2013.01); C07H 19/10 (2013.01); C07H 19/16 (2013.01); C07H 19/20 (2013.01);
Abstract
Provided herein are compounds, compositions and methods for the treatment of Flaviviridae infections, including HCV infections. In certain embodiments, compounds and compositions of nucleoside derivatives are disclosed, which can be administered either alone or in combination with other anti-viral agents. In certain embodiments, provided herein are compounds according to Formula 1001: or a pharmaceutically acceptable salt, solvate, stereoisomeric form, tautomeric form or polymorphic form thereof, wherein Base, Y, Z, A, Rand Rare as described herein.